Overexpression of EGFR in bladder cancer has been widely reported [45–48] and several studies have shown EGFR positivity to be associated with high tumor stage, tumor progression, and poor clinical outcome [46, 48, 49]. This evidence concerns the gene EGFR and urinary bladder carcinoma.